Skip to content
Longterm Wiki

OpenAI Leads $15 Million Seed Round in Red Queen Bio for AI Biosecurity

web
techinformed.com·techinformed.com/openai-leads-15-million-seed-in-red-quee...

Reports on OpenAI's $15M seed investment in Red Queen Bio, an AI biosecurity startup aiming to map AI-enabled biothreats and pre-build medical countermeasures, reflecting growing concern about AI's dual-use potential in biology.

Metadata

Importance: 42/100news articlenews

Summary

Red Queen Bio, spun out of HelixNano, raised a $15 million seed round led by OpenAI to build AI-driven biological defenses. The company plans to map AI-enabled biothreats and develop medical countermeasures using leading AI models, lab automation, and reinforcement learning. This reflects OpenAI's growing investment in biosecurity as a response to AI's potential to lower barriers to bioweapon development.

Key Points

  • •Red Queen Bio raised $15M seed round led by OpenAI, with participation from Cerberus Ventures, Fifty Years, and Halcyon Futures.
  • •The company was spun out of HelixNano and co-founded by Hannu Rajaniemi.
  • •Mission is to 'scale biological defenses' by mapping AI-enabled biothreats and pre-building medical countermeasures.
  • •Approach combines leading AI models, lab automation, and reinforcement learning for biosecurity.
  • •OpenAI's Startup Fund has previously invested in other biosecurity startups like Valthos, indicating a strategic focus area.

Cached Content Preview

HTTP 200Fetched Apr 21, 20261 KB
Breaking News 
 
 
 
 
 
 
 
 
 
 
 
 
 November 14, 2025 
 
 OpenAI leads $15 million seed in Red Queen Bio for AI biosecurity 

 
 
 
 Aman Gupta 
 
 
 November 14, 2025 
 
 
 1 Minutes Read 
 
 -->
 
 
 
 
 
 
 
 
 
 
 Red Queen Bio announced it raised a $15 million seed round led by OpenAI, launching an AI biosecurity company that aims to “scale biological defenses” as AI capabilities advance. 

 The founders wrote that the company was spun out of HelixNano and that the seed includes investors Cerberus Ventures, Fifty Years and Halcyon Futures. 

 They added that the work began with this seed and outlined a plan to map AI-enabled biothreats and pre-build medical countermeasures using leading models, lab automation and reinforcement learning. 

 Co-founder Hannu Rajaniemi separately announced the launch and the $15 million round led by OpenAI in a post linking to the company site. For context, OpenAI’s Startup Fund previously appeared as an investor in Valthos, a biosecurity software startup that introduced itself in a  post .
Resource ID: 6cb8318bf599e64f | Stable ID: sid_3mChuNz3bQ